2Gryglewski RJ, Chlopicki S, Uracz W, et al. Significance of endothelial Prostacyclin and nitric oxide in peripheral and pulmonary circulation[J ]. Med Sci Monit, 2001,7 ( 1 ) : 1 - 16.
3Nishinaga M. Coronary atherosclerosis and vascular endothelial dysfunction[J]. Nippon Rinsho , 2003,61 (suppl 4) :75-79.
4Bautissta LE. Inflammation, endothelial dysfunction; and the risk of high blood pressure: epidemiologic and biological evidence[J]. J Hum Hypertens, 2003,17(4) : 223-230.
5Anferson TL. Nitric oxide, atherosclerosis and the clinical relevance of endothelial dysfunction[J]. Heart Fail Rev,2003,8(1) :71-86.
6Linke A, Recchina F0 Zhang X , et al. Acute and chronic endothelial dysfunction: implications of the development of heart failure[J]. Heart Fail Rev, 2003,8 (1) : 87-97.
7Virchow R. Weitere untersunchungen uber die verstofund der lugreartere undihre folgen [J]. Beitr Exp Pathol Physiol,1846,2(1) :21.
8Dai G,Tsukurov O,Orkin RW,et al. An in vitro cell culture system to study the influence of external[J]. J Vasc Surg,2000,32(5) :977-987.
9Ptine RG, Cunson DE. Rising intersting in nitric oxide synthese[J]. TIBS, 1993,18(2) : 35-36.
10Rien VH, Monique DW, Elza VD, et al. Reduction of blood pressure, plasma cholesterol, and atherosclerosis by elevated endothelial nitric oxide [J]. J Biol Chem, 2002, 1277 (50) :48803-48807.
4Gryglewski Rj,Chlopickis,Uraczw,et al.Significance of endothelial Prostacyclin and nitric oxide in peripheral and pulmonary criculation[J].Med Sci Monit,2001,7(1):1-16.
5Nishinaga M.Coronary atherosclerosis and vascular endothelial dysfunction[J].Nippon Rinsho,2003,61(syppl 4):75-79.
6Bautissta LE.Inflammation,endothelial dysfunction,and the risk of high blood pressure:epidemiologic and biological evidence [ J ].J Hum Hypenteus,2003,17 (4):223-230.
7Anferson TL.Nitric oxide,atherosclerosis and the clinical relevance of endothelial dysfunction[J].Heart Fail Rev,2003,8(1):71-76.
